Health
Sinovac’s COVID-19 vaccine induces quick immune response – study – Reuters
Sinovac Biotech’s experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had…
SINGAPORE/BEIJING (Reuters) – Sinovac Biotechs experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
While the early to mid-stage trials were not designed to assess the efficacy of CoronaVac, researchers said it could provide sufficient protection, based on their experience with other vaccines and data from preclinical studies with macaques.
…
-
Business24 hours agoEnergy shares rip amid Middle East tensions while ASX 200 surges 20% from April low
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 15 June 2025
-
Noosa News23 hours agoElderly driver killed in crash on Mount Coot-tha
-
General22 hours agoSmall team of rowers from Perth represents Australia on world skiffie stage